It is a combination of both. When you invite a country like China, which already has great market access in India for many of its high- and low-value products, to invest in India, making them produce here is import substitution. But ‘Make in India’ is also about those commodities in which India has an advantage, like pharmaceuticals, generic drugs, biomedicines, biotechnology and automotive products. We have an edge in the products we produce in these sectors, having set the bar for quality very high. Therefore, if we are able to manufacture products that are internationally approved, and we expand their production, then you are actually ‘making in India’ products that already have great market access abroad.